hero media helmsley

Helmsley to Co-Host Panel Event With Access to Medicine Foundation on Insulin Access Alongside 2025 World Health Assembly

Geneva, Switzerland | Wednesday, May 21, 2025

Join us during the 78th World Health Assembly in Geneva to for a dynamic event exploring the complex supply and demand challenges affecting insulin access — and the promising solutions to overcome them by registering at the link here to join us in person or virtually.

Co-hosted with Access to Medicine Foundation (ATMF), this conversation will bring together experts from across the pharmaceutical industry, philanthropy, multilateral organizations, and the diabetes community to discuss cross-sector solutions that drive lasting, meaningful change. 

This two-part panel discussion will feature:

  • H.E Dr. Mekdes Daba, Minister of Health, Federal Ministry of Health Ethiopia
  • Jon Fairest, Head of Global Health Unit, Sanofi
  • Carissa Vados, Head of Diabetes Health Equity, Novo Nordisk
  • Robert Lloyd, Associate Vice President Social Impact, Lilly
  • Rhonda Duffy, Chief Operating Officer, Biocon Biologics
  • Emmanuella Selasi Hormenoo, PLWT1D & Secretary General, Diabetes Youth Care
  • Bianca Hemmingsen, Medical Officer, World Health Organization
  • Claudia Martinez, Director of Research, Access to Medicine Foundation
  • James Reid, Program Officer, Helmsley Charitable Trust

Equitable insulin access is possible — but only if we act together. We hope to see you on May 21st, 2025.

Register Here

 

Event graphic featuring the logos of the Helmsley Charitable Trust and the Access to Medicine Foundation in the top right corner. In the center, the event title reads in white and blue font: Unlocking Access to Insulin: Advancing Public-Private Partnerships for Equitable Diabetes Care. Underneath the title are timing details in white font: Wednesday, May 21st, 2025 | 12:00-14:00 CET.

 

More about Helmsley’s Type 1 Diabetes Program

The Type 1 Diabetes (T1D) program is dedicated to helping the global T1D community live safer, better, and more fulfilling lives today while funding advancements in research and technology for a better tomorrow.